Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Sep 4;23(1):297.
doi: 10.1186/s13054-019-2584-5.

Endotoxin removal by polymyxin B: is it a question of dose or duration or both?

Patrick M Honore  1 , David De Bels  2 , Leonel Barreto Gutierrez  2 , Sebastien Redant  2 , Andrea Gallerani  2 , Willem Boer  3
Affiliations
Comment

Endotoxin removal by polymyxin B: is it a question of dose or duration or both?

Patrick M Honore et al. Crit Care. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Comment on

References

    1. Srisawat N, Tungsanga S, Lumlertgul N, Komaenthammasophon C, Peerapornratana S, Thamrongsat N, et al. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients. Crit Care. 2018;22(1):279. doi: 10.1186/s13054-018-2077-y. - DOI - PMC - PubMed
    1. Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, et al. Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA. 2018;320(14):1455–1463. doi: 10.1001/jama.2018.14618. - DOI - PMC - PubMed
    1. De Jong PR, González-Navajas JM, Jansen NJG. The digestive tract as the origin of systemic inflammation. Crit Care. 2016;20:279. doi: 10.1186/s13054-016-1458-3. - DOI - PMC - PubMed
    1. Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med. 2018;44(12):2205–2212. doi: 10.1007/s00134-018-5463-7. - DOI - PMC - PubMed
    1. Pais de Barros JP, Gautier T, Sali W, Adrie C, Choubley H, Charron E, et al. Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay. J Lipid Res. 2015;56(7):1363–1369. doi: 10.1194/jlr.D059725. - DOI - PMC - PubMed